Revive Therapeutics Ltd.

Revive Therapeutics Ltd.

Revive Therapeutics Ltd.

Overview
Date Founded

2012

Headquarters

82 Richmond Street East,Toronto, ON M5C 1P1

Type of Company

Public

Industries

Pharmaceuticals
Wholesale: Consumer Non-Durables/Sundries

Company Description

Revive Therapeutics Ltd. engages in the research, development, and commercialization of novel therapies and technologies for the medical cannabis and cannabinoid pharmaceuticals markets. It offers the Relicann, a proprietary hemp-based cannabidiol chewing gum for the health and wellness. Its novel cannabinoid delivery technology targets diseases and disorders such as pain, inflammation, and wound care. The company was founded by Fabio Chianelli on March 27, 2012 and is headquartered in Vaughan, Canada.

Contact Data
Trying to get in touch with decision makers at Revive Therapeutics Ltd.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Financial Officer

Vice President-Research & Development

Chairman & Chief Executive Officer

Advisor & Principal Investigator

Principal Investigator

Medical Advisor

Senior Clinical & Regulatory Affairs Advisor

Clinical Advisor

Scientific Advisor for Cannabinoid-Based Therapeutics

Scientific Advisor for Cannabinoid-Based Therapeutics Targeting Liver Diseases

Board of Directors

Chief Executive Officer at Attwill Medical Solutions, Inc.

Chairman & Chief Executive Officer at Revive Therapeutics Ltd.

President & Chief Executive Officer at RYM Capital Corp.

Independent Director & Senior Vice President-Corporate Development at Pasofino Gold Ltd.

Paths to Revive Therapeutics Ltd.
Potential Connections via
Relationship Science
You
Revive Therapeutics Ltd.
Recent Transactions
Details Hidden

Revive Therapeutics Ltd. issued Up to CAD Units

Transaction Advisors
Underwriter

Advised onRevive Therapeutics Ltd. issued Up to CAD Units

Auditor

Advised onRevive Therapeutics Ltd. issued Up to CAD Units

Key Stats and Financials As of 2019
Market Capitalization
$2.53M
Total Enterprise Value
$5.6M
Earnings Per Share
$-0.02
Revenue
$0
Net Profit
$-1.34M
TEVNet Income
-4.17x
Total Debt
$0
Total Equity
$961K
EBITDA
$-1.32M
Debt TEV
0x
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Revive Therapeutics Ltd.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Revive Therapeutics Ltd.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Revive Therapeutics Ltd..